Adial Pharmaceuticals Ownership | Who Owns Adial Pharmaceuticals?

Adial Pharmaceuticals Ownership Summary

Adial Pharmaceuticals is owned by 8.52% institutional investors, and 91.48% retail investors. Fidelity Extended Market Index is the top mutual fund, with 0.56% of its assets in Adial Pharmaceuticals shares.

ADIL Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Adial Pharmaceuticals	8.52%	-	91.48%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2023	17	-10.53%	2,253,587	-6.89%	8	10.18%	3	-57.14%	6	-
Mar 31, 2023	19	-	2,420,240	52.08%	9	22.64%	7	-12.50%	6	100.00%
Dec 31, 2022	19	-5.00%	1,591,440	-15.48%	6	11.86%	8	-20.00%	3	50.00%
Sep 30, 2022	20	-23.08%	1,882,923	16.72%	7	16.63%	10	-33.33%	2	-33.33%
Jun 30, 2022	26	13.04%	1,613,169	-47.81%	6	3.72%	15	50.00%	3	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Extended Market Index	35.93K	0.56%	12.81K
BlackRock Extended Equity Market K	17.57K	0.27%	-7.00
Vanguard Institutional Extnd Mkt Idx Tr	9.36K	0.15%	-
Fidelity Series Total Market Index	8.37K	0.13%	7.41K
Extended Equity Market Fund M	2.23K	0.03%	-6.00
Fidelity Nasdaq Composite Index	661.00	0.01%	-
NT Ext Equity Mkt Idx Fd - L	598.00	0.01%	-
Northern Trust Extended Eq Market Idx	598.00	0.01%	-
NT Ext Equity Mkt Idx Fd - NL	520.00	0.01%	-
Fidelity Total Market Index	510.00	0.01%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 29, 2023	Schuyler Kevin	-	Buy	$1.92K
Dec 30, 2021	Newman James W. Jr.	-	Buy	$27.10K
Dec 30, 2021	Newman James W. Jr.	-	Buy	$13.60K
Dec 30, 2021	Newman James W. Jr.	-	Buy	$26.60K
Nov 30, 2021	Stilley William B. III	Chief Executive Officer	Buy	$29.18K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	-
2024 Q1	-	-
2023 Q3	1	-
2023 Q2	-	-
2022 Q4	-	-

ADIL Ownership FAQ

Who Owns Adial Pharmaceuticals?

Adial Pharmaceuticals shareholders are primarily institutional investors at 8.52%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Adial Pharmaceuticals's industry, Biotech Stocks , is 47.04%, which Adial Pharmaceuticals falls below.

Does Blackrock own Adial Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Adial Pharmaceuticals.

Who is the top mutual fund holder of Adial Pharmaceuticals shares?

Fidelity Extended Market Index is the top mutual fund holder of Adial Pharmaceuticals shares, with 0.56% of its total shares outstanding invested in 35.93K Adial Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools